Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$820M |
| 2 |
Microsoft
MSFT
|
+$811M |
| 3 |
McDonald's
MCD
|
+$804M |
| 4 |
Coca-Cola
KO
|
+$655M |
| 5 |
Amazon
AMZN
|
+$646M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.64B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.1B |
| 3 |
Strategy Inc
MSTR
|
+$564M |
| 4 |
Kroger
KR
|
+$558M |
| 5 |
Danaher
DHR
|
+$494M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.33% |
| 2 | Healthcare | 3.23% |
| 3 | Consumer Discretionary | 2.55% |
| 4 | Financials | 2.55% |
| 5 | Industrials | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11926
PUT
Alto Neuroscience
ANRO
$1.26B
| $31.2K | ﹤0.01% |
14,200
-9,700
| -41% | -$23.1K |
|
11927
ProMIS Neurosciences
PMN
$133M
| $31.1K | ﹤0.01% |
+2,537
| New | +$34.6K |
|
|
MOB
11928
Mobilicom Ltd
MOB
$77.1M
| $30.5K | ﹤0.01% |
12,092
+636
| +6% | +$1.25K |
|
|
IMCC
11929
IM Cannabis
IMCC
$1.1M
| $30.4K | ﹤0.01% |
+12,246
| New | +$25.6K |
|
11930
TriSalus Life Sciences Warrant
TLSIW
$18.1M
| $30.4K | ﹤0.01% |
+23,540
| New | +$33.4K |
|
11931
PUT
Maravai LifeSciences
MRVI
$849M
| $30.1K | ﹤0.01% |
12,500
-200
| -2% | -$420 |
|
11932
Cheetah Net Supply Chain Service
CTNT
$5.09M
| $30K | ﹤0.01% |
114
+57
| +100% | +$16K |
|
|
ZTEK
11933
Zentek
ZTEK
$77.3M
| $30K | ﹤0.01% |
27,493
-7,619
| -22% | -$10.6K |
|
11934
SAB Biotherapeutics
SABS
$337M
| $29.9K | ﹤0.01% |
+17,095
| New | +$28.3K |
|
11935
CALL
Tilly's
TLYS
$122M
| $29.8K | ﹤0.01% |
+21,600
| New | +$29.7K |
|
11936
CALL
American Resources Corp
AREC
$308M
| $29.7K | ﹤0.01% |
+35,900
| New | +$28.7K |
|
|
QNME
11937
Quanome Technologies
QNME
$15.9M
| $29.7K | ﹤0.01% |
34,946
+16,127
| +86% | +$15.6K |
|
|
MAMO
11938
Massimo Group
MAMO
$44.1M
| $29.7K | ﹤0.01% |
+13,374
| New | +$31K |
|
|
TE
11939
CALL
T1 Energy
TE
$1.51B
| $29.6K | ﹤0.01% |
24,100
-8,000
| -25% | -$9.75K |
|
11940
PUT
Fossil Group
FOSL
$329M
| $29.6K | ﹤0.01% |
20,000
+14,200
| +245% | +$17.9K |
|
|
SOL
11941
CALL
DELISTED
Emeren Group
SOL
| $29.5K | ﹤0.01% |
15,800
-21,100
| -57% | -$32.9K |
|
11942
Creative Medical Technology
CELZ
$8.04M
| $29.5K | ﹤0.01% |
+11,145
| New | +$24K |
|
|
LITB
11943
LightInTheBox
LITB
$60.8M
| $29.5K | ﹤0.01% |
25,731
-5,499
| -18% | -$7.87K |
|
11944
CALL
Gerdau
GGB
$9.3B
| $29.5K | ﹤0.01% |
10,100
-3,000
| -23% | -$8.22K |
|
11945
CALL
Veru
VERU
$46.5M
| $29.4K | ﹤0.01% |
5,050
-1,990
| -28% | -$11.2K |
|
|
BVC
11946
BitVentures Limited Ordinary Shares
BVC
$2.53B
| $29.4K | ﹤0.01% |
+33,595
| New | +$35.1K |
|
|
BQ
11947
Boqii Holding Ltd
BQ
$8.19M
| $29.3K | ﹤0.01% |
+13,938
| New | +$29.3K |
|
11948
CALL
Castor Maritime
CTRM
$22.6M
| $29.3K | ﹤0.01% |
13,900
-4,600
| -25% | -$10.3K |
|
11949
Catheter Precision
VTAK
$1.01M
| $29.3K | ﹤0.01% |
6,363
+4,628
| +267% | +$25.1K |
|
|
GPMT
11950
PUT
Granite Point Mortgage Trust
GPMT
$57.4M
| $29.1K | ﹤0.01% |
11,800
+3,100
| +36% | +$6.96K |
|
Similar funds
Citadel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Citadel Advisors held 15,819 positions worth $576B, up 9.2% from $527B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Citadel Advisors withdrew a net $29.1B in Q2 2025, closing 3,524 positions and reducing 5,141 holdings. Its most notable exit was Kroger, an estimated $558M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in Walmart Inc worth $401M.
- Citadel Advisors's largest Q2 2025 buy was Walmart Inc: 4,099,492 shares worth $401M.
- Citadel Advisors added most to NVIDIA in Q2 2025, an estimated $820M increase.
- Citadel Advisors's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $1.64B.
- Citadel Advisors fully exited Kroger in Q2 2025, selling an estimated $558M.
- Citadel Advisors's ten largest holdings make up 27% of its $576B portfolio in Q2 2025.
- Citadel Advisors opened 1,459 new positions and closed 3,524 in Q2 2025.
- Citadel Advisors's portfolio value rose 9.2% quarter-over-quarter to $576B.
Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.